Cargando…

Development and validation of a predictive model for end-stage renal disease risk in patients with diabetic nephropathy confirmed by renal biopsy

This study was performed to develop and validate a predictive model for the risk of end-stage renal disease (ESRD) inpatients with diabetic nephropathy (DN) confirmed by renal biopsy. We conducted a retrospective study with 968 patients with T2DM who underwentrenal biopsy for the pathological confir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Lulu, Shang, Jin, Xiao, Jing, Zhao, Zhanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2020
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020820/ https://www.ncbi.nlm.nih.gov/pubmed/32095345 http://dx.doi.org/10.7717/peerj.8499

Ejemplares similares

Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy
por: Wu, Feng, et al.
Publicado: (2021)

Association between serum uric acid and renal outcome in patients with biopsy-confirmed diabetic nephropathy
por: Zou, Yutong, et al.
Publicado: (2021)

Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline
por: Misra, Paraish S., et al.
Publicado: (2020)

Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
por: Ju, Lincheng, et al.
Publicado: (2022)

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma
por: Ma, Sheng, et al.
Publicado: (2023)

From Diabetic Nephropathy to End-Stage Renal Disease: The Effect of Chemokines on the Immune System
por: Qiu, Yuheng, et al.
Publicado: (2023)

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
por: Fu, Yang, et al.
Publicado: (2019)

Identifying DUSP-1 and FOSB as hub genes in immunoglobulin A nephropathy by WGCNA and DEG screening and validation
por: Jianping, Wu, et al.
Publicado: (2022)

Significance of renal biopsy in patients with presumed diabetic nephropathy
por: Harada, Koji, et al.
Publicado: (2013)

Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Mingzhe, et al.
Publicado: (2020)

A 14 immune-related gene signature predicts clinical outcomes of kidney renal clear cell carcinoma
por: Zou, Yong, et al.
Publicado: (2020)

A microRNA‐clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma
por: Zhan, Yating, et al.
Publicado: (2021)

Nodes with high centrality in protein interaction networks are responsible for driving signaling pathways in diabetic nephropathy
por: Abedi, Maryam, et al.
Publicado: (2015)

Key sunitinib‐related biomarkers for renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021)

Endothelial Cell Autoantibodies in Predicting Declining Renal Function, End-Stage Renal Disease, or Death in Adult Type 2 Diabetic Nephropathy
por: Zimering, Mark B., et al.
Publicado: (2014)

Vesicoureteral Reflux, Reflux Nephropathy, and End-Stage Renal Disease
por: Brakeman, Paul
Publicado: (2008)

The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study
por: Shang, Jin, et al.
Publicado: (2019)

Serologic and Histologic Predictors of Long-Term Renal Outcome in Biopsy-Confirmed IgA Nephropathy (Haas Classification): An Observational Study
por: Tsai, Shang-Feng, et al.
Publicado: (2019)

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
por: Zhu, Wenbiao, et al.
Publicado: (2021)

Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy
por: Mise, Koki, et al.
Publicado: (2014)

NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription
por: Wang, Ninghua, et al.
Publicado: (2021)

Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma
por: Tang, Weihao, et al.
Publicado: (2020)

Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
por: Zhao, L., et al.
Publicado: (2021)

AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis
por: Sui, Yingli, et al.
Publicado: (2021)

Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma
por: Zhong, Tingting, et al.
Publicado: (2022)

Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis
por: Hu, Yongzheng, et al.
Publicado: (2023)

Development and validation of a prognostic nomogram to predict overall survival and cancer-specific survival for patients with anaplastic thyroid carcinoma
por: Gui, Weiwei, et al.
Publicado: (2020)

Hypomagnesemia in Type 2 Diabetic Nephropathy: A novel predictor of end-stage renal disease
por: Sakaguchi, Yusuke, et al.
Publicado: (2012)

Risk factors for an early dialysis start in patients with diabetic nephropathy end-stage renal disease
por: Mizuno, Tomohiro, et al.
Publicado: (2014)

Integrative analysis of miRNA–mRNA network in idiopathic membranous nephropathy by bioinformatics analysis
por: He, Wenfang, et al.
Publicado: (2021)

Renal outcomes and prognostic factors in patients with type-2 diabetes and chronic kidney disease confirmed by renal biopsy
por: Jing, Na, et al.
Publicado: (2021)

Renal miR-148b is associated with megalin down-regulation in IgA nephropathy
por: Wen, Lu, et al.
Publicado: (2018)

Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
por: Li, Na, et al.
Publicado: (2021)

IQGAP3 in clear cell renal cell carcinoma contributes to drug resistance and genome stability
por: Li, Wen, et al.
Publicado: (2022)

Spatiotemporal trends and prognosis of end stage renal disease patients with biopsy-proven IgA nephropathy in France, 2010–2014
por: Robert, Thomas, et al.
Publicado: (2020)

Seq2science: an end-to-end workflow for functional genomics analysis
por: van der Sande, Maarten, et al.
Publicado: (2023)

Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
por: Ma, Wei, et al.
Publicado: (2021)

Fast and accurate semantic annotation of bioassays exploiting a hybrid of machine learning and user confirmation
por: Clark, Alex M., et al.
Publicado: (2014)

Development and validation of a predictive model for the progression of diabetic kidney disease to kidney failure
por: Cheng, Yaqi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lgr683nr7rdn2mj0vn28efns9n